1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical and demographic summary for study samplea
Overall GBM NGG Other No. of subjects 44 32 10 2 Age (yr) 60.2 (13.7) 62.4 (11.6) 50.3 (15.3) 75.5 (13.4) Overall survival (mo) 40.4 (61.5) 35.3 (64.9) 64.3 (46.1) 2.0 (0) Radiation treatment (y/n) 39/5 29/3 10/0 0/2 Chemotherapy (y/n) 40/4 30/2 10/0 0/2 Tumor-treating fields (y/n) 28/16 16/16 0/10 0/2 Other treatment (y/n) 7/37 5/27 2/8 0/2 Time between last MR imaging and death (days) 63.0 (62.1) 49.6 (42.3) 111.8 (93.1) 33.0 (13.4)
Note:—Y/n indicates yes/no.
↵a Quantitative values are presented as mean (SD).